DNA Sequencing Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)

DNA Sequencing Market – Report Overview

Pacific Business Consulting’s “DNA Sequencing Market in 10MM – Market Outlook, Unmet Needs, Market Assessment & Forecast (2023-2030)” report offers a comprehensive understanding of DNA Sequencing market, encompassing historical and projected market size data, along with market trends, market drivers, market barriers and unmet medical needs in the Ten Major Markets (10MM) of the United States, Germany, Spain, Italy, France, the United Kingdom, Japan, China, Australia, and India.

The global DNA Sequencing market was approximately valued at US$ 8.2 Billion in 2022 and is expected to exhibit a compound annual growth rate (CAGR) of over 15.0% during the forecast period from 2023 to 2030, aiming to reach a projected value of US$ 19.0 Billion by 2030.

DNA sequencing, a technology capable of sequencing multiple DNA strands through massive parallelization, encompasses both Sanger’s and non-Sanger’s sequencing methods. Offering advantages such as cost-effectiveness, high accuracy, speed, and precise results even from low sample input, DNA sequencing has gained prominence over microarray and other genomic analysis methods. Widely utilized for applications such as biomarker discovery, oncology studies, personalized medicine, and forensics, DNA sequencing has streamlined nucleotide analysis, gradually replacing conventional genomics tools like microarrays and genotyping. The increased demand for DNA sequencing is propelled by a surge in sequencing applications, technological advancements, a rise in genome mapping programs globally, and increased investment in research and development.

The continuous progress in sequencing technology and bioinformatics has enabled the identification of DNA variations, including those associated with increased disease risk. Next-generation sequencing (NGS) and whole-genome sequencing (WGS) have allowed the simultaneous testing of a broad range of genes in a single diagnostic platform, expanding the utility of DNA sequencing in clinical diagnosis applications. Personalized targeted sequencing of tumors has accelerated mutation identification, aiding in the development of pharmacological treatments targeting specific cancer-related pathways. The global-scale projects utilizing NGS protocols have contributed to foundational knowledge in oncology precision medicine.

Initiatives such as CVS Health’s Transform Oncology Care, launched in December 2019, leverage genomics technology to create personalized cancer treatment plans. The demand for DNA sequencing technologies has surged due to the exponential increase in COVID-19 cases, with rapid genomic sequencing projects being employed for monitoring viral spread and guiding future treatments. Notably, collaborations like the one between the National Health Service of the UK, Genomics England, Genetics of Mortality in Critical Care, and Illumina have aimed to generate whole-genome sequences of COVID-19-affected individuals.

DNA sequencing has revolutionized proteomic and genomic research by providing highly accurate and high-throughput technology for applications such as de novo assembly, WGS, and DNA resequencing. Academic research institutes, like the Whitehead Institute for Biomedical Research in Massachusetts, U.S., have adopted this technology, exemplified by the installation of Illumina’s NovaSeq 6000 Sequencing System in June 2020.

Efforts from organizations like the Center for Medicare and Medicaid Services (CMS), the Association for Molecular Pathology, and commercial payers, including Blue Cross Blue Shield and Aetna, have aimed to boost the clinical usage of sequencing technologies. Notably, in January 2020, CMS expanded coverage for NGS-based diagnostic tests for ovarian and breast cancer patients, providing enhanced opportunities for personalized cancer care.

Key players in the DNA Sequencing segment, such as PerkinElmer U.S. LLC., PacBio, BGI, Bio-Rad Laboratories, Inc., Myriad Genetics, Inc., PierianDx, Intrexon Bioinformatics Germany GmbH, Eurofins Scientific, Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Illumina, Inc., QIAGEN, F. Hoffmann-La Roche Ltd., Oxford Nanopore Technologies plc, and Macrogen, Inc., are poised to shape the future landscape of DNA Sequencing technologies through ongoing innovation.

Scope of Report

The report addresses critical subjects such as strategic competitor evaluation, market characterization, unmet needs, and the consequences of these elements for the DNA Sequencing market. It also delves into the analysis of present and prospective market competition within the global DNA Sequencing market.

Furthermore, the report offers an insightful examination of the primary industry drivers, constraints, and challenges. Each trend undergoes independent research to furnish qualitative analysis regarding its implications.

Reasons to Buy

• Develop your business strategies by gaining insights into the trends that shape and drive the DNA Sequencing market across the 10MM (Ten Major Markets).
• Increase revenue by comprehending key trends, innovative products and technologies, market segments, and companies poised to influence the future of the 10MM DNA Sequencing market.
• Craft effective sales and marketing strategies by thoroughly understanding the competitive landscape and analyzing the performance of various competitors.
• Identify emerging players with potentially robust product portfolios and devise strategic counter-strategies to gain a competitive advantage.
• Optimize your sales and marketing efforts by pinpointing market categories and segments that offer the greatest opportunities for consolidations, investments, and strategic partnerships.

1. Executive Summary: DNA Sequencing
   • Global Market Outlook: DNA Sequencing
2. Competitive Intelligence Analysis: DNA Sequencing
3. Therapeutic Sector SWOT
4. Technology Roadmap Analysis: DNA Sequencing
5. Market Background
   • Drivers
   • Restraints
   • Opportunity
   • Key Market Trends
   • Key Unmet Needs
6. Key Marketed Products Profile – Major Approved Products: DNA Sequencing
   • Product Profile
   • Safety and Efficacy
7. Regulatory Landscape
8. DNA Sequencing: Ten Major Market (10MM) – Market Analysis, By Technology
   • Next-Generation Sequencing
   • Third Generation DNA Sequencing
   • Sanger Sequencing
9. DNA Sequencing: Ten Major Market (10MM) – Market Analysis, By Application
   • Diagnostics
   • Biomarkers & Cancer
   • Reproductive Health
   • Personalized Medicine
   • Others
10. DNA Sequencing: Ten Major Market (10MM) – Market Analysis, By End User
    • Pharmaceutical & Biotechnology Companies
    • Research & Academic Institutions
    • Hospitals & Clinics
    • Others
11. DNA Sequencing: Ten Major Market (10MM) – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

12. S. DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

13. K. DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

14. Germany DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

15. France DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

16. Italy DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

17. Spain DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

18. Japan DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

19. China DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

20. Australia DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

21. India DNA Sequencing – Market Analysis
    • Historical Market Analysis (US$ million), 2020-2022
      • By Technology
      • By Application
      • By End User
    • Current and Future Market Projections (US$ million), 2023-2030
      • By Technology
      • By Application
      • By End User

22. Competitive Landscape
    • Company Overview
    • Product Portfolio
    • Key Financials
    • Sales Footprint

Note – All Major Company Profiles (Count up to 20) will be covered in the report

23. Assumptions and Acronyms Used
24. Research Methodology
    • Secondary Research
    • Primary Research
    • Data Triangulation
25. Geographic Scope
    • The U.S., The U.K., Germany, France, Italy, Spain, Japan, China, Australia, and India
26. Copyrights and Disclaimer